Company Cheilbio Co., Ltd.

Equities

A052670

KR7052670007

Pharmaceuticals

End-of-day quote Korea S.E. 23:00:00 19/07/2023 BST 5-day change 1st Jan Change
2,080 KRW -9.96% Intraday chart for Cheilbio Co., Ltd. -.--% -.--%

Business Summary

Cheilbio Co., Ltd. is a Korea-based company engaged in the manufacturing of veterinary drugs. The Company's offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, diagnostic kits including enzyme-linked immunosorbent assay (ELISA) test kits, virus test kits and deoxyribonucleic acid (DNA) kits, as well as feed additives. The Company’s products are used for cattle, pigs, chickens, pets and other animals. It supplies its products mainly to the domestic market.

Number of employees: 76

Sales per Business

KRW in Million2022Weight2023Weight Delta
Treatments and Others
43.7 %
3,846 25.1 % 5,290 43.7 % +37.57%
Product Level
27.5 %
4,480 29.2 % 3,325 27.5 % -25.79%
Fermented Products
18.1 %
2,360 15.4 % 2,190 18.1 % -7.21%
Functional Additives
8.9 %
4,509 29.4 % 1,077 8.9 % -76.12%
Diagnosis Kit
1.4 %
127 0.8 % 167 1.4 % +31.51%
Other
0.5 %
26 0.2 % 62 0.5 % +133.82%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
15,349 100.0 % 12,111 100.0 % -21.10%

Managers

Managers TitleAgeSince
Chief Executive Officer 84 -
Comptroller/Controller/Auditor 36 -
Comptroller/Controller/Auditor 81 -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 84 -
Director/Board Member 57 -
Director/Board Member 49 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 29,129,064 19,641,386 ( 67.43 %) 2,117,388 ( 7.269 %) 67.43 %

Company contact information

Cheil Bio Co., Ltd.

131 Sandan-ro 83 beon-gil Danwon-gu

15605, Ansan-si

+

http://www.cheilbio.com
address Cheilbio Co., Ltd.(A052670)
  1. Stock Market
  2. Equities
  3. A052670 Stock
  4. Company Cheilbio Co., Ltd.